Monogram, Pfizer Extend PGx Collaboration | GenomeWeb

NEW YORK (GenomeWeb News) – Monogram Biosciences today said that Pfizer has exercised its right to extend the collaborative agreement between the firms regarding marketing of Monogram's Trofile test with Pfizer's maraviroc (Selzentry) drug.

The firms have been making the Trofile assay available on a global basis in support of the launches of Selzentry, which is used to treat CCR5-tropic HIV-1. The assay helps physicians determine which patients would benefit from treatment with the drug.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.